People who get cochlear implants to treat severe hearing loss may develop new bone growth in the ear — and it may lessen any hearing they have left, a new study hints.
India's Central Drugs Standard Control Organisation (CDSCO) has granted Syntellix the license to bring five different product families of its revolutionary bioabsorbable magnesium-based implants to market.